The latest generation of AD mouse models avoids the overexpression of FAD mutations and is focused on risk genes, such as Triggering receptor expressed on myeloid cells 2 (TREM2) [165] and Apolipoprotein E4 (APOE4) [166]. The gene discussed is TREM2; the disease is Alzheimer disease.